World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
32416
World Ranking
13528
National Ranking
6880

Overview

Jay S. Skyler is affiliated with the University of Miami in the United States and has an extensive research record primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans multiple subfields, with a significant focus on Endocrinology, Diabetes and Metabolism, as well as Genetics, Surgery, Immunology, and Infectious Diseases.

The scientist's research topics predominantly involve Diabetes and associated disorders, Diabetes Management and Research, and Pancreatic function and diabetes. Additional focus areas include Diabetes Treatment and Management, Immune Cell Function and Interaction, COVID-19 Clinical Research Studies, and the intersection of Metabolism, Diabetes, and Cancer.

Jay S. Skyler has frequently published in the following venues:

  • Journal of Diabetes
  • Diabetes Care
  • Diabetes
  • Diabetologia
  • The Lancet Diabetes & Endocrinology

Among their recent significant publications are:

  • "Practical recommendations for the management of diabetes in patients with COVID-19" (2020), published in The Lancet Diabetes & Endocrinology
  • "The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)" (2021), published in Diabetes Care
  • "The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)" (2021), published in Diabetologia
  • "COVID-19 and metabolic disease: mechanisms and clinical management" (2021), published in The Lancet Diabetes & Endocrinology
  • "Novel therapies with precision mechanisms for type 2 diabetes mellitus" (2021), published in Nature Reviews Endocrinology

The scientist maintains collaborative relationships with several frequent co-authors, including Jay M. Sosenko, Juliana C.N. Chan, Heba M. Ismail, Hertzel C. Gerstein, and Zachary T. Bloomgarden, reflecting ongoing research partnerships in their domain.

Best Publications

  • Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association

    Jay S. Skyler;Richard Bergenstal;Robert O. Bonow;John Buse

  • Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association.

    Richard A. Insel;Jessica L. Dunne;Mark A. Atkinson;Jane L. Chiang

  • Effects of insulin in relatives of patients with type 1 diabetes mellitus

    J. S. Skyler;D. Brown;H. P. Chase;E. Collier

  • Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

    Mark D. Pescovitz;Carla J. Greenbaum;Heidi Krause-Steinrauf;Dorothy J. Becker

  • The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Richard I. G. Holt;Richard I. G. Holt;J. Hans DeVries;Amy Hess-Fischl;Irl B. Hirsch

  • An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

    Kevan C. Herold;Brian N. Bundy;S. Alice Long;Jeffrey A. Bluestone

  • Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis

    Jay S. Skyler;George L. Bakris;Ezio Bonifacio;Tamara Darsow

  • Practical recommendations for the management of diabetes in patients with COVID-19.

    Stefan R. Bornstein;Francesco Rubino;Francesco Rubino;Kamlesh Khunti;Geltrude Mingrone;Geltrude Mingrone

  • Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

    Skyler Js;Krischer Jp;Wolfsdorf J;Cowie C

  • C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve β-Cell Function: Report of an ADA Workshop, 21–22 October 2001

    Jerry P. Palmer;G. Alexander Fleming;Carla J. Greenbaum;Kevan C. Herold

  • Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

    Tihamer Orban;Brian Bundy;Dorothy J Becker;Linda A DiMeglio

  • Validation of the insulin sensitivity index (ISI0,120): comparison with other measures ☆

    Miriam Gutt;Catherine L. Davis;Susan B. Spitzer;Maria M. Llabre

  • Insulin action during pregnancy. Studies with the euglycemic clamp technique

    Edmond A Ryan;Mary Jo O'Sullivan;Jay S Skyler

  • Diabetes trends in the USA.

    Jay S. Skyler;Carolyn Oddo

  • The economic burden of diabetes and the benefits of improved glycemic control: the potential role of a continuous glucose monitoring system.

    Jay S. Skyler

  • Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

    Jay S. Skyler;Richard Bergenstal;Robert O. Bonow;John Buse

  • Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study.

    Jay S. Skyler;William T. Cefalu;Ione A. Kourides;William H. Landschulz

  • Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

    Diane K Wherrett;Brian Bundy;Dorothy J Becker;Linda A DiMeglio

  • Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors’ Expert Forum

    William T. Cefalu;Sanjay Kaul;Hertzel C. Gerstein;Rury R. Holman

  • Rituximab, B-lymphocyte depletion, and preservation of beta-cell function

    Mark D. Pescovitz;Carla J. Greenbaum;Heidi Krause-Steinrauf;Dorothy J. Becker

Frequent Co-Authors

Jerry P. Palmer
Jerry P. Palmer University of Washington
Carla J. Greenbaum
Carla J. Greenbaum Virginia Mason Medical Center
Jeffrey P. Krischer
Jeffrey P. Krischer University of South Florida
Desmond A. Schatz
Desmond A. Schatz University of Florida
Kevan C. Herold
Kevan C. Herold Yale University
Neil Schneiderman
Neil Schneiderman University of Miami
Linda A. DiMeglio
Linda A. DiMeglio Indiana University
Antoinette Moran
Antoinette Moran University of Minnesota
Darrell M. Wilson
Darrell M. Wilson Stanford University
Dorothy J. Becker
Dorothy J. Becker University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in medicine but want flexible options, numerous online degrees can jumpstart your journey. Many students explore fast track medical programs, such as Licensed Practical Nurse (LPN) pathways, to quickly enter the healthcare workforce. These accelerated courses are ideal for those seeking practical experience and swift employment.

For those aiming to specialize, programs like the fastest psychiatric nurse practitioner program let you become an advanced practice nurse in mental health through a streamlined online curriculum. This is an excellent option for prospective students targeting high-demand specialties.

If your interests lie in leadership or administration, look into earning an online master of health administration. This degree prepares graduates for management roles in clinics, hospitals, and health organizations. Cost is an important factor, so it’s wise to compare programs based on tuition and fees, as highlighted in this guide on masters in healthcare administration cost.

Online healthcare degrees offer flexibility and diverse career pathways, making them a practical option for aspiring medical professionals. Explore the available programs to find the path that best matches your goals.

Best Scientists Citing Jay S. Skyler

Trending Scientists